Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.002 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |